IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Chinese Patent Drug Manufacturing in China Industry Data and Analysis
Skepticism about the effectiveness of Western medicine in China has led to the rising popularity of Chinese patent medicine, which is considered to be less toxic and have fewer side effects. Increasingly, patients are choosing traditional Chinese medicine as their primary treatment. Additionally, the aging population and increasing health consciousness are factors contributing to industry demand. Along with the implementation of the Healthy China strategy, reforms in the medical and healthcare system have continued to deepen.
Access this data your way
The Chinese Patent Drug Manufacturing in China Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the Chinese Patent Drug Manufacturing industry in China includes market sizing, forecasting, data and analysis from 2014-2029. The most recent publication was released May 2024.
About this industry
What's this industry report about?
The Chinese Patent Drug Manufacturing industry in China operates under the industry code 2740. The Chinese Patent Drug Manufacturing industry in China processes Chinese herbs to produce traditional Chinese patent medicine in capsule, powder, and liquid forms. Chinese traditional medicine pills are not manufactured by this industry (see IBISWorld industry report 2730). Related terms covered in the Chinese Patent Drug Manufacturing industry in China include good manufacturing practice (gmp), health drugs and specialty drugs.
What's included in this industry?
Products and services covered in Chinese Patent Drug Manufacturing industry in China include Drugs for cardiovascular and cerebrovascular diseases, Health drugs and Drugs for common diseases.
What companies are included in this industry?
The Chinese Patent Drug Manufacturing industry in China is highly fragmented with no companies holding a market share greater than 5%.
Performance
What's included in the Performance chapter?
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Chinese Patent Drug Manufacturing industry in China.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
Products & Markets
What's included in the Products and Markets chapter?
The Products and Markets chapter covers detailed product and service segmentation, analysis of major markets and international trade data for the for the Chinese Patent Drug Manufacturing industry in China.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
Geographic Breakdown
What's included in the Geographic Breakdown chapter?
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Chinese Patent Drug Manufacturing industry in China.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
Competitive Forces
What's included in the Competitive Forces chapter?
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Chinese Patent Drug Manufacturing industry in China. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
Companies
What's included in the Companies chapter?
The Companies chapter covers Key Takeaways, Market Share and Companies in the Chinese Patent Drug Manufacturing industry in China. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
External Environment
What's included in the External Environment chapter?
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Chinese Patent Drug Manufacturing industry in China. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
Financial Benchmarks
What's included in the Financial Benchmarks chapter?
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Chinese Patent Drug Manufacturing industry in China. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
Industry Data
What's included in the Industry Data chapter?
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Chinese Patent Drug Manufacturing industry in China.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is the market size of the Chinese Patent Drug Manufacturing industry in China in 2026?
The market size of the Chinese Patent Drug Manufacturing industry in China is $143.4bn in 2026.
How many businesses are there in the Chinese Patent Drug Manufacturing industry in China in 2024?
There are 2,313 businesses in the Chinese Patent Drug Manufacturing industry in China, which has grown at a CAGR of 1.9 % between 2019 and 2024.
How may import tariffs affect the Chinese Patent Drug Manufacturing industry in China?
The Chinese Patent Drug Manufacturing industry in China is unlikely to be materially impacted by import tariffs with imports accounting for a low share of industry revenue.
How may export tariffs affect the Chinese Patent Drug Manufacturing industry in China?
The Chinese Patent Drug Manufacturing industry in China is unlikely to be materially impacted by export tariffs with exports accounting for a low share of industry revenue.
Has the Chinese Patent Drug Manufacturing industry in China grown or declined over the past 5 years?
The market size of the Chinese Patent Drug Manufacturing industry in China has been growing at a CAGR of 1.9 % between 2019 and 2024.
What is the forecast growth of the Chinese Patent Drug Manufacturing industry in China over the next 5 years?
Over the next five years, the Chinese Patent Drug Manufacturing industry in China is expected to grow.
What does the Chinese Patent Drug Manufacturing industry in China include?
Drugs for cardiovascular and cerebrovascular diseases and Health drugs are part of the Chinese Patent Drug Manufacturing industry in China.
How competitive is the Chinese Patent Drug Manufacturing industry in China?
The level of competition is moderate and increasing in the Chinese Patent Drug Manufacturing industry in China.
Cut through the noise with intelligence you can trust
